From Infacts to Adolescents: The Importance of Children's Health and Safety

Pediatrics Journal

Subscribe to Pediatrics Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Pediatrics Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories

SAN ANTONIO, Jan. 26, 2012 /PRNewswire/ -- Mission Pharmacal Company announces the recent formation of Alamo Pharma Services.  This new business unit, a wholly owned subsidiary of Mission, will provide pharmaceutical sales teams with operational and human resources (HR) support.  Alamo will be headquartered in Doylestown, Pennsylvania, expanding Mission's Northeastern United States presence, which also includes the company's Commercial Group operations and BioComp Pharma, Mission's lifecycle management and generics company. "Alamo is an outgrowth of my grandfather, H.N. Walsdorf's, longstanding commitment to service excellence.  The organization was created to be a strategic partner for the Mission sales teams, providing best-in-class operational support," notes Neill Walsdorf Jr, president of Mission Pharmacal Company.  "Alamo enables Mission to take advantage of ... (more)

New Analysis Shows Lower Mortality Rates and Less Need for Redosing When Treating Neonatal Respiratory Distress Syndrome With CUROSURF(R) vs. Survanta(R)

CARY, NC -- (Marketwire) -- 01/26/12 -- Cornerstone Therapeutics (NASDAQ: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the hospital and respiratory markets, announced a new analysis published in the eFirst Pages section of the Pediatrics website reporting significant benefits in mortality rate and the need for redosing when treating neonatal respiratory distress syndrome (RDS) with Cornerstone's CUROSURF® (poractant alfa) Intratracheal Suspension(1). The objective of the independently performed meta-analys... (more)

Virtua Adopts Nuvon’s VEGA System for its Enterprise-wide Device Connectivity Needs

Nuvon, Inc. (www.nuvon.com), the leader in next generation medical device connectivity and interoperability solutions, today announced that Virtua has gone live with the first phase of its enterprise-wide device connectivity infrastructure starting with connectivity to the Picis Peri-Operative System utilizing Nuvon’s standards-based, open architecture VEGA™ System. Virtua is a comprehensive healthcare system headquartered in Marlton, N.J. and includes four hospitals, an ambulatory care center in Camden and a wide range of other services, including health and wellness centers, r... (more)

Myca Health Adds New Primary Care Clients Serving 10,000 Patients to its Hello Health® Community

NEW YORK, Jan. 25, 2012 /PRNewswire/ -- Myca Health Inc. announced today that in the past month primary care practices serving over 10,000 patients have contracted to implement the Hello Health® Patient Management platform. The company recently signed agreements with family practice, internal medicine, pediatric and integrative medicine practices in five states. Hello Health is a free Patient Management platform integrating an electronic health record, an online patient health portal and a suite of secure, web-based communication tools designed to connect patients with the... (more)

UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study

CLEVELAND, Jan. 24, 2012 /PRNewswire/ -- Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and efficacy of the Moxy™ Drug Coated Balloon for the treatment of peripheral arterial disease (PAD).  Co-investigators Sahil Parikh, MD,  Michael Cunningham MD, and Vikram Kashyap, MD, with UH Harrington-McLaughlin Heart & Vascular Institute at UH Case Medical Center, were the first physicians to successfully implant the device in a patient.  LEVANT 2, sponsored by m... (more)